AtriCure (ATRC) Reports In-Line Q3 EPS; Guides FY15 Revenue Above Consensus
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $28.44 -1.25%
Revenue Growth %: +11.7%
Financial Fact:
Loss from operations: -6.29M
Today's EPS Names:
JFIN, KEQU, LASE, More
Revenue Growth %: +11.7%
Financial Fact:
Loss from operations: -6.29M
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q3 EPS of ($0.22), in-line with the analyst estimate of ($0.22). Revenue for the quarter came in at $31.4 million versus the consensus estimate of $31.38 million.
AtriCure sees FY2015 revenue of $129.5-130.5 million, versus the consensus of $128.6 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Keurig Dr Pepper coffee chief to depart ahead of planned split
- Pfizer lung cancer drug misses survival goal in Phase 3 trial
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
